These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9964

  • 1. Assessment of drugs in schizophrenia. Basic trial design.
    Lader M.
    Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):375-9. PubMed ID: 9964
    [Abstract] [Full Text] [Related]

  • 2. Dose selection and comparator drugs in schizophrenia research.
    Kane JM.
    J Clin Psychiatry; 2001 Jun; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [Abstract] [Full Text] [Related]

  • 3. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW, Gueorguieva RV, Baker CB, Makuch RW.
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [Abstract] [Full Text] [Related]

  • 4. The CATIE study.
    Teich J.
    Am J Psychiatry; 2006 Mar; 163(3):554-5; author reply 555-6. PubMed ID: 16513894
    [No Abstract] [Full Text] [Related]

  • 5. Patient-oriented randomisation: A new trial design applied in the Neuroleptic Strategy Study.
    Schulz C, Timm J, Cordes J, Gründer G, Mühlbauer B, Rüther E, Heinze M.
    Clin Trials; 2016 Jun; 13(3):251-9. PubMed ID: 27016729
    [Abstract] [Full Text] [Related]

  • 6. Schizophrenia and antipsychotic somatic treatment.
    Lindström LH, Wieselgren IM.
    Int J Technol Assess Health Care; 1996 Jun; 12(4):573-84. PubMed ID: 9136468
    [Abstract] [Full Text] [Related]

  • 7. Emerging guidelines for the use of antipsychotic polypharmacy.
    Stahl SM.
    Rev Psiquiatr Salud Ment; 2013 Jun; 6(3):97-100. PubMed ID: 23485567
    [No Abstract] [Full Text] [Related]

  • 8. Assessment of drugs in schizophrenia. Discussion on basic trial design.
    Coppen A.
    Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):381-3. PubMed ID: 791325
    [No Abstract] [Full Text] [Related]

  • 9. New antipsychotic medications: strategies for evaluation and selected findings.
    Schooler NR.
    Schizophr Res; 1997 Oct 30; 27(2-3):249-59. PubMed ID: 9416654
    [Abstract] [Full Text] [Related]

  • 10. Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond.
    Nasrallah HA.
    J Clin Psychiatry; 2007 Oct 30; 68 Suppl 1():3-4. PubMed ID: 17286521
    [No Abstract] [Full Text] [Related]

  • 11. Maintenance therapy and the natural course of schizophrenia.
    Davis JM.
    J Clin Psychiatry; 1985 Nov 30; 46(11 Pt 2):18-21. PubMed ID: 2865252
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Review of treatments that can ameliorate nonadherence in patients with schizophrenia.
    Kane JM.
    J Clin Psychiatry; 2006 Nov 30; 67 Suppl 5():9-14. PubMed ID: 16822091
    [Abstract] [Full Text] [Related]

  • 14. Risks of intermittent antipsychotic treatment in schizophrenia.
    Suzuki T, Nomura K, Watanabe K.
    J Clin Psychiatry; 2011 Jan 30; 72(1):114; author reply 114-5. PubMed ID: 21272519
    [No Abstract] [Full Text] [Related]

  • 15. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA.
    J Clin Psychiatry; 1984 May 30; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [Abstract] [Full Text] [Related]

  • 16. Management strategies for the treatment of schizophrenia.
    Kane JM.
    J Clin Psychiatry; 1999 May 30; 60 Suppl 12():13-7. PubMed ID: 10372604
    [Abstract] [Full Text] [Related]

  • 17. Iloperidone: A new drug for the treatment of schizophrenia.
    Arif SA, Mitchell MM.
    Am J Health Syst Pharm; 2011 Feb 15; 68(4):301-8. PubMed ID: 21289324
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluating characteristics of patient selection and dropout rates.
    Keith SJ.
    J Clin Psychiatry; 2001 Feb 15; 62 Suppl 9():11-4; discussion 15-6. PubMed ID: 11379825
    [Abstract] [Full Text] [Related]

  • 20. Assessment of drugs in schizophrenia. Discussion on diagnosis and patient selection.
    Johnson DA.
    Br J Clin Pharmacol; 1976 Jun 15; 3(3 Suppl 2):371-3. PubMed ID: 791324
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.